Detection of and screening for XXXX .

@entity1204 @entity172 @entity1 @entity28 @entity5 @entity14577 @entity10094 @entity189 @entity3202 @entity1613
@entity1204 occurs more than twice as frequently as @entity5 . The main risk factors are age, @entity172 use, and @entity28 . Increasing life expectancy and more liberal use of @entity172 to prevent @entity14577 will probably increase the magnitude of the problem. @entity1204 is a heterogeneous disease. Good prognosis is associated with @entity28 and @entity172 use and with @entity189 preceded by @entity1613 . A bad prognosis may be found in @entity1 without major risk factors and is associated with a normal or @entity3202 endometrium. Because of a high prevalence of @entity10094 (6.9 per 1,000) and because the group with a poor prognosis is usually asymptomatic, all postmenopausal @entity1 should be screened at least one time. For screening, the use of one of the cytologic instruments is recommended; these instruments are safe, easy to handle, and can be used in the office setting without anesthesia. Yields are comparable to dilation and curettage. Family physicians are encouraged to familiarize themselves with cytologic instruments and to use them for screening postmenopausal @entity1 in their office.
